<DOC>
	<DOCNO>NCT00291213</DOCNO>
	<brief_summary>This placebo-controlled study design learn levetiracetam effective tardive dyskinesia .</brief_summary>
	<brief_title>Levetiracetam Treatment Tardive Dyskinesia</brief_title>
	<detailed_description />
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>meet Glazer Morgenstern criterion TD none</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>